Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
暂无分享,去创建一个
Louis J. Picker | L. Picker | A. Sylwester | J. Nelson | B. L. Mitchell | J. Edgar | Cara Taormina | Christian Pelte | F. Ruchti | P. Sleath | K. Grabstein | N. Hosken | F. Kern | Florian Kern | Jay A. Nelson | Franziska Ruchti | Paul R. Sleath | Andrew W. Sylwester | Bridget L. Mitchell | John B. Edgar | Cara Taormina | Christian Pelte | Kenneth H. Grabstein | Nancy A. Hosken
[1] V. Maino,et al. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. , 2000, The Journal of infectious diseases.
[2] M. Weekes,et al. Identification of Naive or Antigen-Experienced Human CD8+ T Cells by Expression of Costimulation and Chemokine Receptors: Analysis of the Human Cytomegalovirus-Specific CD8+ T Cell Response1 , 2002, The Journal of Immunology.
[3] D. Lilleri,et al. Human Cytomegalovirus Proteins pp65 and Immediate Early Protein 1 Are Common Targets for CD8+ T Cell Responses in Children with Congenital or Postnatal Human Cytomegalovirus Infection1 , 2004, The Journal of Immunology.
[4] E. Remmerswaal,et al. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. , 2003, Blood.
[5] F. Kern,et al. Analysis of antigen-specific T-cell responses with synthetic peptides--what kind of peptide for which purpose? , 2004, Human immunology.
[6] M. Girndt,et al. Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity1 , 2003, Transplantation.
[7] G. Pawelec,et al. Large Numbers of Dysfunctional CD8+ T Lymphocytes Bearing Receptors for a Single Dominant CMV Epitope in the Very Old , 2003, Journal of Clinical Immunology.
[8] C. Pitcher,et al. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. , 1997, The Journal of clinical investigation.
[9] R. Welsh,et al. Immunological Memory to Viral Infections1 , 2004 .
[10] M. Menzies,et al. Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers , 2003, Journal of Virology.
[11] C. Pitcher,et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. , 2001, Journal of immunological methods.
[12] B. Gärtner,et al. Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent Virus , 2002, Journal of Virology.
[13] S. Hansen,et al. Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.
[14] B. Gärtner,et al. Age-related decrease in adenovirus-specific T cell responses. , 2002, The Journal of infectious diseases.
[15] S. Riddell,et al. Deficient cellular immunity--finding and fixing the defects. , 1999, Science.
[16] R. Würzner,et al. Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+ T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons , 2005, Journal of Virology.
[17] L. Picker,et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. , 2002, The Journal of infectious diseases.
[18] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[19] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[20] D. Lewis,et al. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. , 2004, The Journal of infectious diseases.
[21] Laxmi Parida,et al. In Silico Pattern-Based Analysis of the Human Cytomegalovirus Genome , 2003, Journal of Virology.
[22] J. Schneider-Mergener,et al. Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited , 1999, Journal of Virology.
[23] I. Rigoutsos,et al. Reevaluation of human cytomegalovirus coding potential , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Richard D. Smith,et al. Identification of Proteins in Human Cytomegalovirus (HCMV) Particles: the HCMV Proteome , 2004, Journal of Virology.
[25] M. Reddehase. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance , 2002, Nature Reviews Immunology.
[26] 藤井 良知. Cytomegalovirus , 1966, Definitions.
[27] P. Moss,et al. Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals1 , 2002, The Journal of Immunology.
[28] A. Bertoletti,et al. Heterologous T cell immunity in severe hepatitis C virus infection , 2005, The Journal of experimental medicine.
[29] S. Riddell,et al. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. , 2004, Blood.
[30] N. Alp,et al. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein , 1991, Journal of virology.
[31] S. Riddell,et al. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes , 1994, Journal of medical virology.
[32] P. Moss,et al. Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection1 , 2004, The Journal of Immunology.
[33] G. Pawelec,et al. Is immunosenescence infectious? , 2004, Trends in immunology.
[34] L. Ginaldi,et al. Immunosenescence and infectious diseases. , 2001, Microbes and infection.
[35] Hans-Georg Rammensee,et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. , 2002, Blood.
[36] R. Myers,et al. Coding potential of laboratory and clinical strains of human cytomegalovirus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[37] E Tom,et al. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains , 1996, Journal of virology.
[38] J. Bell,et al. Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors , 2000, Journal of Virology.
[39] J. Sissons,et al. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses , 1988, The Journal of experimental medicine.
[40] E. Mocarski. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system , 2004, Cellular microbiology.
[41] S. Migueles,et al. The Functional Profile of Primary Human Antiviral CD8+ T Cell Effector Activity Is Dictated by Cognate Peptide Concentration , 2004, The Journal of Immunology.
[42] R. Welsh,et al. Immunological memory to viral infections. , 2004, Annual review of immunology.
[43] P. Klenerman,et al. Expansion of Protective CD8+ T-Cell Responses Driven by Recombinant Cytomegaloviruses , 2004, Journal of Virology.